Mar 26th, 2015
Are Biotech Stocks Overvalued and in a Bubble?
Clearbridge Investments Health Care Analyst Marshall Gordon discusses the performance of biotech stocks. Bloomberg’s Drew Armstrong also speaks on “Market Makers.”” (Source: Bloomberg)
Mar 26th, 2015
Are Biotech Stocks Overvalued and in a Bubble?
Clearbridge Investments Health Care Analyst Marshall Gordon discusses the performance of biotech stocks. Bloomberg’s Drew Armstrong also speaks on “Market Makers.”” (Source: Bloomberg)